Jove
Visualize
Contact Us

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

7.7K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.7K
Apoptosis01:30

Apoptosis

11.9K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Necrosis01:16

Necrosis

4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Autophagic Cell Death01:18

Autophagic Cell Death

3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.

Nature biomedical engineering·2026
Same author

Time-Dependent Association Between Invasive Procedures, Carbapenem Exposure, and Multidrug-Resistant Bloodstream Infection in Critically Ill Patients.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same author

6''-O-acetylsaikosaponin D targets STAT3-mediated transcriptional remodeling to induce ferroptosis and apoptosis.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Extraperitoneal Single-Port Robot-Assisted Bilateral Retroperitoneal Lymph Node Dis-section for Primary Non-Seminomatous Germ Cell Tumor: Technique and Surgical Considerations.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same author

Updates to gene-disease classifications and inheritance patterns for porphyrias.

Molecular genetics and metabolism·2026
Same author

Flexible and navigable suction ureteral access sheath combined with flexible ureteroscopy for proximal impacted ureter stones: a retrospective case series.

World journal of urology·2026
Same journal

A Low Serum Calcium-to-Potassium Ratio Predicts Postpartum Venous Thromboembolism Risk: Mediation by Hemoglobin and D-Dimer in a Multicenter Cohort.

MedComm·2026
Same journal

The Dual Roles of Regulatory B Cells in Infection, Cancer, and Immunity.

MedComm·2026
Same journal

Discovery and Structural Characterization of a Highly Protective Neutralizing Antibody Targeting the Mpox Virus A35R Protein.

MedComm·2026
Same journal

Generative Artificial Intelligence and Large Language Models in Clinical Oncology.

MedComm·2026
Same journal

EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer.

MedComm·2026
Same journal

RNA Modifications in Tumor Microenvironment: A New Dimension for Cancer Treatment.

MedComm·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 9, 2025

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

15.1K

Programmed Cell Death in Cancer.

Yuang Wei1,2,3,4, William Hankey5, Dongliang Xu2,3,4

  • 1Cancer Research Center School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine Shanghai China.

Medcomm
|September 3, 2025
PubMed
Summary
This summary is machine-generated.

Programmed cell death (PCD) pathways are crucial for eliminating aberrant cells, but their dysregulation fuels cancer development and treatment resistance. This review synthesizes PCD mechanisms and their therapeutic manipulation in diverse cancers, focusing on ferroptosis and prostate cancer.

Keywords:
anticancer therapycancerferroptosisprogrammed cell deathprostate cancer

More Related Videos

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
06:12

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

2.3K
Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
12:44

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells

Published on: October 11, 2012

23.5K

Related Experiment Videos

Last Updated: Sep 9, 2025

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

15.1K
Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
06:12

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

2.3K
Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
12:44

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells

Published on: October 11, 2012

23.5K

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Cancer remains a leading global cause of death despite advances in treatment.
  • Dysregulation of programmed cell death (PCD) pathways contributes to cancer initiation and resistance to therapies.
  • Understanding PCD mechanisms is vital for developing effective cancer treatments.

Purpose of the Study:

  • To provide a comprehensive review of the discovery, roles, and mechanisms of major PCD forms in cancer.
  • To explore the interconnections and crosstalk between different PCD modalities.
  • To discuss the manipulation of PCD pathways by various cancer therapies and highlight therapeutic opportunities, with a focus on ferroptosis and prostate cancer.

Main Methods:

  • Comprehensive literature review of preclinical and clinical evidence.
  • Synthesis of molecular mechanisms, dual functions, and alterations of PCD pathways in various cancer types.
  • Analysis of therapeutic strategies targeting PCD, including chemotherapy, radiotherapy, immunotherapy, and targeted agents.

Main Results:

  • Detailed overview of apoptosis, necroptosis, autophagy, pyroptosis, ferroptosis, and cuproptosis in cancer.
  • Elucidation of the complex crosstalk and interconnections among different PCD pathways.
  • Demonstration of how diverse cancer therapies engage and modulate specific PCD pathways.

Conclusions:

  • Programmed cell death pathways are intricately linked to cancer biology and therapeutic responses.
  • Targeting specific PCD modalities, particularly ferroptosis, offers promising translational opportunities for precision oncology.
  • Further research into PCD mechanisms and their manipulation can lead to novel and more effective cancer treatment strategies, especially in malignancies like prostate cancer.